Gaucher Disease
Reference40 articles.
1. Abrahamov, A., Elstein, D., Horowitz, M., et al. (1995). A new Gaucher disease variant characterized by progressive calcification of heart valves and unique genotype. Lancet, 346, 1000–1003. 2. Aerts, J. M., Kallemeijn, W. W., Wegdam, W., Joao Ferraz, M., van Breemen, M. J., Dekker, N., et al. (2011). Biomarkers in the diagnosis of lysosomal storage disorders: Proteins, lipids, and inhibodies. Journal of Inherited Metabolic Disease, 34, 605–619. 3. Allen, M. J., Myer, B. J., Khokher, A. M., Rushton, N., & Cox, T. M. (1997). Pro-inflammatory cytokines and the pathogenesis of Gaucher’s disease: Increased release of interleukin-6 and interleukin-10. QJM, 90, 19–25. 4. Barak, V., Acker, M., Nisman, B., Kalickman, I., Abrahamov, A., Zimran, A., et al. (1999). Cytokines in Gaucher’s disease. European Cytokine Network, 10, 205–210. 5. Barton, N. W., Brady, R. O., Dambrosia, J. M., et al. (1991). Replacement therapy for inherited enzyme deficiency–macrophage-targeted glucocerebrosidase for Gaucher’s disease. New England Journal of Medicine, 324, 1464–1470.
|
|